Dr John William Fox Jr, MD | |
4000 Wellness Dr, Midland, MI 48670-2000 | |
(989) 839-3000 | |
Not Available |
Full Name | Dr John William Fox Jr |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 13 Years |
Location | 4000 Wellness Dr, Midland, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841587920 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 4301099009 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Self Regional Healthcare | Greenwood, SC | Hospital |
Cox Medical Centers | Springfield, MO | Hospital |
Abbeville Area Medical Center | Abbeville, SC | Hospital |
Pottstown Hospital | Pottstown, PA | Hospital |
Metro Health Hospital | Wyoming, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Geisinger Clinic | 5395657001 | 2866 |
Virtual Radiologic Professionals Llc | 4981608817 | 355 |
Houlton Regional Hospital | 0042127946 | 24 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | Midland Radiology Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861419954 PECOS PAC ID: 5294798963 Enrollment ID: O20041104000742 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | Virtual Radiologic Professionals Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932342029 PECOS PAC ID: 4981608817 Enrollment ID: O20071004000582 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | Geisinger Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558313023 PECOS PAC ID: 5395657001 Enrollment ID: O20181218003005 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | Palm Desert Radiology Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124079868 PECOS PAC ID: 0749173789 Enrollment ID: O20190214003050 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | Mori Bean And Brooks Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20190730000895 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | West Florida Radiology Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396724654 PECOS PAC ID: 0941224612 Enrollment ID: O20190828001128 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | Geisinger-hm Joint Venture Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396207015 PECOS PAC ID: 1355676370 Enrollment ID: O20200318001583 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Entity Name | United Memorial Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669747085 PECOS PAC ID: 0547259376 Enrollment ID: O20230929001847 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John William Fox Jr, MD 4000 Wellness Dr, Midland, MI 48670-2000 Ph: (989) 839-3000 | Dr John William Fox Jr, MD 4000 Wellness Dr, Midland, MI 48670-2000 Ph: (989) 839-3000 |
News Archive
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The COVID-19 pandemic is affecting millions of people around the world and has taken a toll of over 411,000 lives. Yet after five months, there are immense gaps in our knowledge as to the factors that increase or inhibit viral transmission.
A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).
› Verified 6 days ago
Stephen Pavlock, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Vincent Dimerc, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Richard Montpetit, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Charles A Guidot, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-1644 Fax: 989-839-3029 | |
Michael P Bartlett, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Praful Desai, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3408 | |
Rajesh Kotecha, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-1339 |